课题基金 / 基金详情

Isolation of osteoclast-forming factor produced by stromal cells and mechanism of osteoclast differentiation

Isolation of osteoclast-forming factor produced by stromal cells and mechanism of osteoclast differentiation
基质细胞产生的破骨细胞形成因子的分离及破骨细胞分化机制
批准号:
03670864
负责人:
MORITA Ikuo
金额:
$1.34万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1992

项目摘要

项目成果

MORITA Ikuo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
I have succeeded to isolate the stromal cell line, which can support osteoclast formation from spleen cells and named as TMS-14 and 14. Using these stromal cells we studied the mechanism of osteoclast formation. As a result, osteoclast formation will be necessary for cAMP elevation in the stromal cells and an activation of A-kinase. And also the contact between spleen cells and stromal cells is also needed. Therefore, we next studied what adhesion molecule is important for osteoclast formation. In stromal cells ICAM-1 was expressed and in osteoclast progenitor cells LFA-1 and ICAM-1 were expressed. The antibodies for ICAM-1 and LFA-1 was added in the osteoclast formation system, the formation of osteoclast was significantly suppressed. However, the inhibition rate was only 50%. These results suggest that the other adhesion molecules was involved for osteoclast formation.Stromal cells release osteoclast formation-stimulating factors as well as inhibiting factors. We failed to isolate the stimulators, but succeeded to characterize the inhibitory factors for osteoclast formation. The inhibitor was released from osteoblasts as well as stromal cells and the moleculr weight will be over 10000. The inhibitor can be regulated by some anti-osteoporosis drugs. This means that some drugs for osteoporosis affects via a production of this inhibitor for osteoclast formation.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
K.Toriyama,I.Morita S.Murota: "The existence of distinct class of prostaglandin E2 receptors mediating adenylate cyclase and phospholipase C pathways in osteoblastic clone,MC3T3ーE1" Prostagl.Leukotri.and EFA.
K.Toriyama、I.Morita S.Murota:“在成骨细胞克隆 MC3T3-E1 中存在介导腺苷酸环化酶和磷脂酶 C 途径的不同类别的前列腺素 E2 受体”Prostagl.Leukotri. 和 EFA。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
I.Morita et al: "Iprifavone inhibits murine osteoclast formation in vitro" Calcified Tissue International. 51. S7- 10 (1992)
I.Morita 等人:“Iprifavone 在体外抑制小鼠破骨细胞形成”Calcified Tissue International。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K. Toriyama, I. Morita, Y. Seyama, S. Yamashita, S. Murota: "Variation of increases in free cytosolic calcium ion induced by prostaglandin E2 in mouse osteoblast clone, MC3T3-E1" J. Bone and Mineral Research. 9. 34-38 (1991)
K. Toriyama、I. Morita、Y. Seyama、S. Yamashita、S. Murota:“小鼠成骨细胞克隆 MC3T3-E1 中前列腺素 E2 诱导的游离胞质钙离子增加的变化”J. 骨与矿物质研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
I. Morita, K. Sakaguchi, T. Kurachi, S. Murota: "Ipriflavone inhibits murine osteoclast formation in vitro" Calcified Tissue International. 51. s7-s10 (1992)
I. Morita、K. Sakaguchi、T. Kurachi、S. Murota:“伊普黄酮在体外抑制小鼠破骨细胞形成”钙化组织国际。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
15
    Development of novel therapies for myopia by printing technology
    • 批准号:
      25670728
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      MORITA Ikuo
    • 依托单位:
    A novel periodontal tissue regeneration method using a printing technology
    • 批准号:
      24390442
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.15万
    • 财政年份:
      2012
    • 负责人:
      MORITA Ikuo
    • 依托单位:
    Development of tissue engineering for three-dimensional tissue regeneration
    • 批准号:
      22659354
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.06万
    • 财政年份:
      2010
    • 负责人:
      MORITA Ikuo
    • 依托单位:
    Mechanism for maintenance of homeostasis of several functions by connexin 43
    • 批准号:
      20390470
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.15万
    • 财政年份:
      2008
    • 负责人:
      MORITA Ikuo
    • 依托单位:
    海外基金